Explaining Tumor-Infiltrating Lymphocytes As a Cancer Treatment
ACGT Awards Research Grant to Develop Oncolytic Virus for Glioblastoma
Funding from ACGT will help Chiocca perform FDA-required studies on mice to show the oncolytic virus is safe and can be manufactured for humans. It is the second such grant awarded to Chiocca from ACGT.
Prioritizing Cell and Gene Therapy Research for Pancreatic Cancer
ACGT is advancing cell and gene therapy research for pancreatic tumors and other types of cancer.
Efforts to Advance Cell and Gene Therapies for Breast Cancer
October is National Breast Cancer Awareness Month, and thus serves as an additional moment to point to the progress made in cell and gene therapy development, as well as the lingering challenges.
Immune Checkpoint Inhibitors Versus CAR T-Cell Therapy
The term “immunotherapy” has quite a wide scope in cancer treatment. A lot of different therapies fall within the umbrella of immunotherapy, and two of the most successful are CAR T-cell therapies and immune checkpoint inhibitors.
Bypassing the Blood Brain Barrier to Treat Brain Cancer
The barrier is an essential part of keeping the brain safe, but it also prevents the immune system from eliminating brain cancer tumors.
"Remote-Controlled" CAR-T Technology Can Help Personalize Cell Therapy for Cancer
Crystal Mackall, MD, an Alliance for Cancer Gene Therapy scientist, is helping create a remote-control technology to personalize CAR T-cell therapy for each cancer patient.
2 Commerce Drive Cranbury, NJ 08512